Nexxus Scotland

ClinTec International and HCG celebrate a successful partnership in delivering Global Patient Recruitment Services at European Drug Conference, DIA.

04 March 2010

Dr Rabinder Buttar, President & CEO of ClinTec International and Frank S. Kilpatrick, President of Healthcare Communications Group (HCG), El Segundo, C A will celebrate their companies' successful collaboration at the upcoming 22^nd Annual Drug Information Association (DIA) EuroMeeting in Monaco on March 8-10, 2010. These clinical trial management firms have recently completed several successful global undertakings, "Our prompt ramp up in multiple study engagements is where we really shine,"

stated Buttar, who touted the recent successful completion of the first portion of a 12-trial joint international osteoarthritis recruitment engagement spanning three continents. "It is impressive results like this that give us much to celebrate,"

said Buttar. "We knew our two companies could together dramatically help our clients gain greater operational efficiencies while trimming recruitment timelines,"

said Kilpatrick. He added that this constituted their largest global engagement thus far, borne of an exclusive partnership vision. The EuroMeeting event will be held at the Grimaldi Forum.

ClinTec provides immediate access to global patient recruitment services in over 40 countries, complementing HCGs strong base in the US.  The union represents a perfect cohesion of U.S., European, Middle East, North African and Latin American interests according to HCG Senior Vice President, Jeanne Meadow. "All of our clients benefit from this relationship because our in-country teams expand our mutual reach,"

said Meadows. Echoing this sentiment, Kilpatrick stated, "We don't have to outsource because we have all the experts from scientific advisors to site specialists under one umbrella."

Together, ClinTec and HCG possess main offices, located in Glasgow, UK; Krakow, Poland; Bangalore, India; Beirut, Lebanon; Dubai, UAE; Philadelphia, US; and Los Angeles, US, along with ClinTec's regional presence and registered offices in over 40 countries.

No strangers to DIA conferences around the world, ClinTec leadership has attended prior meetings in Budapest, Vienna, Prague, and Paris, among others. Their excitement regarding the upcoming DIA EuroMeeting in Monaco is high. "It's a fantastic opportunity to develop existing relationships and forge new ones at Euro DIA, there is no better medium than face to face contact for this,"

stated Buttar. Alongside ClinTec and HCG leadership, will be their senior team members to reach out to all DIA attendees during and after conference events. "This is where European pharmaceutical leadership meets and has proved invaluable to our global expansion,"

said Meadow.

The collaboration of ClinTec and HCG initially focused on recruitment and retention services for their clients, but has been rapidly expanding. "We are receiving acknowledgement for our efforts and that has produced enquiries into our other core competencies and services, including global feasibility, site selection and study management process improvement," said Buttar. "We're pleased to have received the attention of some of pharma's biggest and most innovative companies and are solidly committed to advancing their clinical opportunities,"

stated Buttar. As the ClinTec and HCG teams celebrate their mutual accomplishments, their leadership welcomes the opportunity to celebrate this success with the event attendees, "There are several significant trends underway globally that influence recruitment and we'd like to share our findings and make Global Patient Recruitment Services accessible to all companies in every region of the world."

For media enquiries contact Tristan Jervis, T: 00 44 207 861 3019, E: t.jervis@defacto.com.

Back